IMMX — Immix Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Immix Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17.6	13.4	17.5	17.7	100
Net Total Receivables	0.026	0.256	1.17	1.97	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.2	14.9	19.8	20.2	101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.006	0.004	0.05	2.73	3.49
Other Long Term Assets
Total Assets	18.2	14.9	19.9	22.9	105
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.202	1.27	3.72	8.69	10.1
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.202	1.75	3.52	9.7	11
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	18	13.2	16.4	13.3	93.8
Total Liabilities & Shareholders' Equity	18.2	14.9	19.9	22.9	105
Total Common Shares Outstanding